# Phase 2 osteosarcoma trials recruiting: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials in phase 2 for osteosarcoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 osteosarcoma trials: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/osteosarcoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 15, 2026 | NCT07820033 | Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial | University Health Network, Toronto | Phase 2 | Not yet recruiting | Advanced Cancer, Stage IV Solid Tumor Cancer, Stage IV Sarcoma of Bone, Stage IV Lymphoma, Stage IV Melanoma, Endocrine... | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820033) |
| August 26, 2026 | NCT07787429 | Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma | Sponsor not shown (see the record) | Phase 2 | Recruiting | Osteosarcoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787429) |
| May 22, 2026 | NCT07602049 | Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma | Sun Yat-sen University | Phase 2 | Recruiting | Soft Tissue Sarcoma (STS), Osteosarcoma | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602049) |
| May 1, 2026 | NCT07560826 | The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma | Wake Forest University Health Sciences | Phase 2 | Recruiting | Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07560826) |
| March 17, 2026 | NCT07477457 | A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Osteosarcoma, Metastasis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07477457) |
| March 3, 2026 | NCT07444918 | Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors | Tianjin Medical University Cancer Institute and Hospital | Phase 2 | Not yet recruiting | Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma... | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07444918) |
| February 24, 2026 | NCT07428993 | Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk... | St. Jude Children's Research Hospital | Phase 2 | Recruiting | Pediatric Osteosarcoma | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07428993) |
| January 7, 2026 | NCT07321912 | Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma | Milton S. Hershey Medical Center | Phase 2 | Recruiting | Osteosarcoma, Ewing Sarcoma | 406 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321912) |
| August 27, 2025 | NCT07142863 | Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 | Not yet recruiting | Osteosarcoma, Neoadjuvant Therapy, Neoadjuvant Chemotherapy, PD-L1 Antibody, Envafolimab | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07142863) |
| December 3, 2024 | NCT06714383 | Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma | Peking University People's Hospital | Phase 2 | Recruiting | Osteosarcoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06714383) |
| August 26, 2024 | NCT06571734 | XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or... | Northwestern University | Phase 2 | Recruiting | Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Bone Sarcoma, Translocation-associated Soft Tissue Sarcoma... | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06571734) |
| July 29, 2024 | NCT06524778 | Single High-dose Brachytherapy for Giant Osteosarcoma Masses | Shanghai Jiao Tong University Affiliated Sixth People's Hospital | Phase 2 | Not yet recruiting | Osteosarcoma | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06524778) |
| November 2, 2023 | NCT06114225 | Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a... | Ruijin Hospital | Phase 2 | Recruiting | Osteosarcoma | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06114225) |
| October 10, 2023 | NCT06074692 | PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) | Ruijin Hospital | Phase 2 | Recruiting | Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06074692) |
| September 18, 2023 | NCT06041490 | Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation | Peking Union Medical College Hospital | Phase 2 | Not yet recruiting | Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma, High-Risk Cancer | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06041490) |
| April 26, 2023 | NCT05830123 | ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas | Hansoh BioMedical R&D Company | Phase 2 | Recruiting | Osteosarcoma, Sarcoma | 170 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05830123) |
| January 10, 2022 | NCT05182164 | Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas | Institut Bergonié | Phase 2 | Recruiting | Soft Tissue Sarcoma Adult, Advanced Soft-tissue Sarcoma, Ewing Sarcoma, Osteosarcoma, Undifferentiated Pleomorphic... | 119 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05182164) |
| November 26, 2021 | NCT05135975 | A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors | Nationwide Children's Hospital | Phase 2 | Recruiting | Neuroblastoma, Sarcoma | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05135975) |
| August 25, 2021 | NCT05019703 | Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study | M.D. Anderson Cancer Center | Phase 2 | Recruiting | Locally Advanced Osteosarcoma, Metastatic Osteosarcoma, Recurrent Osteosarcoma, Refractory Osteosarcoma, Unresectable... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05019703) |
| February 17, 2021 | NCT04758000 | Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse | Istituto Ortopedico Rizzoli | Phase 2 | Recruiting | Osteosarcoma, Ewing Sarcoma | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04758000) |
| January 7, 2021 | NCT04698785 | Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients | Centre Leon Berard | Phase 2 | Recruiting | Bone Sarcoma, Osteosarcoma | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04698785) |
| November 5, 2020 | NCT04616560 | Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell... | National Cancer Institute (NCI) | Phase 2 | Recruiting | Desmoplastic Small Round Cell Tumor, Osteosarcoma, Recurrent Desmoplastic Small Round Cell Tumor, Recurrent Kidney... | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04616560) |
| July 31, 2019 | NCT04040205 | Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration | Medical College of Wisconsin | Phase 2 | Recruiting | Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04040205) |
| March 5, 2013 | NCT01804634 | Reduced Intensity Haploidentical BMT for High Risk Solid Tumors | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 | Recruiting | Refractory and/or Relapsed Metastatic Solid Tumors | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01804634) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Ruijin Hospital | 2 |
| Northwestern University | 1 |
| Centre Leon Berard | 1 |
| Medical College of Wisconsin | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University Health Network, Toronto | 1 |
| [Hansoh BioMedical R&D Company](https://specstream.ai/data/clinical-trials/company/hansoh-biomedical-r-and-d-company) | 1 |
| M.D. Anderson Cancer Center | 1 |
| Shanghai Jiao Tong University Affiliated Sixth People's Hospital | 1 |
| Peking University People's Hospital | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| St. Jude Children's Research Hospital | 1 |
| Wake Forest University Health Sciences | 1 |
| Sun Yat-sen University | 1 |
| National Cancer Institute (NCI) | 1 |
| Istituto Ortopedico Rizzoli | 1 |
| Milton S. Hershey Medical Center | 1 |
| Institut Bergonié | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| Nationwide Children's Hospital | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Peking Union Medical College Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 10 |
| China | 7 |
| France | 2 |
| Canada | 1 |
| Poland | 1 |
| Italy | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Nursing services in the United States](https://specstream.ai/data/businesses/nursing-services/united-states)
- [Trucking companies in the United States](https://specstream.ai/data/businesses/trucking-companies/united-states)
- [Cocktail bars in the United States](https://specstream.ai/data/businesses/cocktail-bars/united-states)
- [Insulation contractors in the United States](https://specstream.ai/data/businesses/insulation-contractors/united-states)
- [Retaining wall suppliers in the United States](https://specstream.ai/data/businesses/retaining-wall-suppliers/united-states)
- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
